TheraVet SA (EPA:ALVET)
0.0820
0.00 (0.00%)
Inactive · Last trade price
on Apr 17, 2025
TheraVet Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Cash & Equivalents | 0.71 | 1.15 | 3.19 | 5.63 | 2.17 | 0.08 |
Cash & Short-Term Investments | 0.71 | 1.15 | 3.19 | 5.63 | 2.17 | 0.08 |
Cash Growth | -59.31% | -63.99% | -43.43% | 159.82% | 2561.78% | - |
Accounts Receivable | 0.02 | 0.02 | 0.03 | 0.01 | 0.01 | 0.12 |
Other Receivables | 0.35 | 0.36 | 0.25 | 0.32 | 0.17 | 0.34 |
Receivables | 0.37 | 0.38 | 0.28 | 0.33 | 0.18 | 0.46 |
Inventory | 0.13 | 0.12 | 0.09 | 0.2 | - | - |
Other Current Assets | -0 | 0 | - | - | - | - |
Total Current Assets | 1.22 | 1.65 | 3.56 | 6.16 | 2.35 | 0.55 |
Property, Plant & Equipment | 0.02 | 0.02 | 0.03 | 0.03 | 0.02 | 0.01 |
Long-Term Investments | 0.01 | 0.01 | 0.01 | 0.02 | 0.16 | 0.01 |
Other Intangible Assets | 5.34 | 0.3 | 0.28 | 0.27 | 0.07 | 1.52 |
Long-Term Deferred Charges | 0.36 | 5.37 | 5.44 | 4.81 | 2.51 | - |
Other Long-Term Assets | 0.2 | 0.19 | 0.18 | 0.16 | -0 | -0 |
Total Assets | 7.15 | 7.53 | 9.5 | 11.45 | 5.11 | 2.09 |
Accounts Payable | 0.2 | 0.13 | 0.14 | 0.54 | 0.29 | 0.08 |
Accrued Expenses | 0.21 | 0.11 | 0.22 | 0.17 | 0.13 | 0.08 |
Current Portion of Long-Term Debt | 0.46 | 0.16 | 0.15 | 0.09 | - | - |
Current Income Taxes Payable | 0 | - | 0.03 | 0.02 | 0 | 0 |
Other Current Liabilities | - | 0.09 | 0.55 | 0.08 | 0.61 | 0.03 |
Total Current Liabilities | 0.87 | 0.48 | 1.08 | 0.89 | 1.02 | 0.19 |
Long-Term Debt | 0.99 | 1 | 0.9 | 0.91 | 0.7 | 0.35 |
Other Long-Term Liabilities | -0 | -0 | 0 | - | - | - |
Total Liabilities | 1.87 | 1.48 | 1.98 | 1.8 | 1.72 | 0.54 |
Common Stock | 0.32 | 0.32 | 0.32 | 0.32 | 0.25 | 0.13 |
Additional Paid-In Capital | 9.85 | 9.85 | 9.85 | 9.85 | 2.87 | 1.12 |
Retained Earnings | -6.69 | -5.84 | -4.27 | -1.96 | -0.62 | -0.23 |
Comprehensive Income & Other | 1.8 | 1.72 | 1.62 | 1.43 | 0.89 | 0.53 |
Shareholders' Equity | 5.28 | 6.05 | 7.52 | 9.65 | 3.39 | 1.55 |
Total Liabilities & Equity | 7.15 | 7.53 | 9.5 | 11.45 | 5.11 | 2.09 |
Total Debt | 1.45 | 1.16 | 1.05 | 1 | 0.7 | 0.35 |
Net Cash (Debt) | -0.74 | -0.01 | 2.14 | 4.63 | 1.47 | -0.27 |
Net Cash Growth | - | - | -53.83% | 215.30% | - | - |
Net Cash Per Share | -0.23 | -0.00 | 0.66 | - | - | - |
Filing Date Shares Outstanding | 3.22 | 3.22 | 3.22 | - | - | - |
Total Common Shares Outstanding | 3.22 | 3.22 | 3.22 | - | - | - |
Working Capital | 0.34 | 1.16 | 2.48 | 5.26 | 1.33 | 0.36 |
Book Value Per Share | 1.64 | 1.88 | 2.33 | - | - | - |
Tangible Book Value | -0.07 | 5.75 | 7.24 | 9.38 | 3.32 | 0.03 |
Tangible Book Value Per Share | -0.02 | 1.78 | 2.25 | - | - | - |
Machinery | - | 0.05 | 0.05 | 0.04 | 0.03 | 0.02 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.